Related Experiment Video
Updated: Jul 6, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Emerging paradigms in the management of malignant pleural effusions
1Albert Einstein Medical Center, Philadelphia PA, USA. Khaleeqg@einstein.edu
Abstract:
Malignant pleural effusions (MPE) are a common clinical problem in patients with neoplastic disease. The development of MPEs in advanced malignancies can cause significant morbidity and mortality. Predominant symptoms of dyspnea, cough, and chest discomfort are usually debilitating. Given the poor prognosis of majority of these patients, palliation is more desirable than cure of an individual complication. Despite multiple new therapies placement of chest tube with sclerotherapy remains the standard of care. The purpose of this article is to review the emerging therapeutic options for MPE management.
Insights
Malignant pleural effusions (MPE) significantly impact cancer patients, causing debilitating symptoms. This review explores emerging treatments beyond the standard chest tube and sclerotherapy for better MPE palliation.
Area of Science:
- Pulmonology
- Oncology
- Palliative Care
Background:
- Malignant pleural effusions (MPE) are a frequent complication in advanced cancer.
- MPEs contribute significantly to patient morbidity and mortality.
- Debilitating symptoms like dyspnea and chest discomfort are common.
Purpose of the Study:
- To review emerging therapeutic options for managing malignant pleural effusions.
- To provide an overview of current and novel MPE treatments.
- To discuss palliative strategies for MPE patients.
Main Methods:
- Literature review of emerging therapies for MPE.
- Analysis of current standards of care for MPE management.
- Synthesis of data on novel treatment approaches.
Main Results:
- Chest tube with sclerotherapy remains the primary treatment.
- Several new therapeutic strategies are under investigation.
- Focus is on palliation due to poor prognosis.
Conclusions:
- Emerging therapies offer potential improvements in MPE management.
- Further research is needed to establish new standards of care.
- Optimizing palliation remains the key goal for MPE patients.
Related Concept Videos
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Disorders: Types and Brief Description
Pneumothorax-II
Clinical Manifestations:
Pneumonia V: Nursing management and Prevention
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed.
Pleura of the Lungs

